Table 18.
| |||||
---|---|---|---|---|---|
Compd | R | IC50a (μM) | Compd | R | IC50a (μM) |
SF-11 | 4-OC2H5 | 0.199 | 158 | 4-CON(C2H5)2 | 0.078 |
150 | -H | NAc | 159 | 4-SO2N(CH3)2 | 0.019 |
151 | 4-OCH3 | 1.1 | 160 | 4-SO2N(C2H5)2 | 0.136 |
152 | 4-OiPr | 1.77 | 161 | 3-OCH3 | 8.162b |
153 | 4-OCF3 | 1.047 | 162 | 3- COOC2H5 | 0.238b |
154 | 4-nC3H7 | 0.777 | 163 | 3-Cl, 4-N(C2H5)2 | 0.085 |
155 | 4-N(C2H5)2 | 0.072b | 164 | 3-CN, 4-OC2H5 | 0.323 |
156 | 4-COOC2H5 | 0.207 | 165 | 2-CH3, 4- OC2H5 | NA |
157 | 4-CON(CH3)2 | 0.301 | 166 | 2-F, 4- OC2H5 | 1.35 |
Functional activity using cAMP biosensor assy. All compounds were inactive at the NPY Y1 receptor
exhibited partial antagonism
not active (NA) at the highest concentration tested (10 μM).